Missouri Jury Rules for Bayer in Roundup Cancer Trial Brought by Three Women

4.2 · 1d ago · US · FINANCE

The Facts

  • A jury in St. Louis, Missouri, rejected claims by three women that Bayer's Roundup weedkiller caused their cancers. ✓2 · DW, Bloomberg
  • Bayer is awaiting a separate court ruling on its proposed $7.25 billion settlement of tens of thousands of other Roundup cases. ✓2 · DW, Bloomberg
  • The Missouri jury's verdict for Bayer's subsidiary Monsanto was unanimous. DW only
  • The plaintiffs, Theresa Aretino, Cynthia Fernandez and Betty Larkin, said they were diagnosed with non-Hodgkin lymphoma after regularly using Roundup; the case was brought in 2020. DW only
  • It is the first Roundup trial since a US Supreme Court ruling (Durnell) that limits complaints over the product. DW only
Dive deeper · 5 more factsShow less
  • The Supreme Court ruled that plaintiffs could not argue the Roundup label failed to warn of cancer risk, since the EPA had concluded the label does not require a cancer warning. DW only
  • The three plaintiffs were not participating in Bayer's settlement; about 65,000 other cases have been filed against the company. DW only
  • Plaintiffs' attorneys argued Roundup was defectively designed and unreasonably dangerous and that Bayer was negligent in selling it. DW only
  • Monsanto's US general counsel Bill Dodero said the verdict shows there is no evidence to prove design defect, fraud or negligence claims, and that plaintiffs face significant challenges after the Durnell ruling. DW only
  • The EPA has previously concluded glyphosate is probably not carcinogenic and is conducting a new safety review; the IARC concluded in 2015 it was 'probably carcinogenic' to humans, a finding Bayer rejects. DW only

Context

A St. Louis jury found in favor of Bayer and its Monsanto subsidiary in a trial brought by three women who alleged Roundup weedkiller caused their non-Hodgkin lymphoma. It is the first such trial since the US Supreme Court's Durnell ruling limiting label-based failure-to-warn claims.

Bayer is seeking court approval of a $7.25 billion settlement covering tens of thousands of other Roundup cases. The three plaintiffs in this trial were not part of that settlement. Bloomberg reported the verdict bolsters the company's effort to contain litigation costs.

How the Agent Panel Scored This

Independent AI personas each scored importance 1–10; the story's score is a trimmed mean (highest and lowest votes dropped). Vote spread: 2.

6 Business Analyst A unanimous jury verdict for Bayer in a first post-Durnell Roundup trial is market-relevant for Bayer's litigation exposure and the pending $7.25 billion settlement, but it is a single case with three plaintiffs and does not itself change the broader liability picture dramatically.
5 Policy Expert A jury verdict for Bayer in a single cancer trial is a concrete legal outcome with meaningful implications for about 65,000 pending Roundup cases and the $7.25 billion settlement, but its direct impact is limited to three plaintiffs, so it sits in the moderate range.
4 Global Affairs Analyst A single jury verdict in a three-plaintiff case is a concrete event with some signal for the broader Roundup litigation and the Durnell ruling's effect, but its direct impact is limited to these plaintiffs and the pending settlement remains separate.
4 News Editor A single jury verdict in an individual cancer lawsuit is a concrete event with notable implications for the thousands of pending Roundup cases, but its direct impact on the general public is limited.
4 Informed Citizen A single jury verdict in one trial for three plaintiffs is a minor concrete event, though it signals how post-Durnell Roundup litigation may proceed for the many pending cases.
4 Science & Tech Analyst A single jury verdict in a three-plaintiff case is a concrete event with some industry and legal significance, but its direct impact on the broader public is limited, though it bears on tens of thousands of pending cases and the Durnell precedent.
4 Critical Reader A single jury verdict in one three-plaintiff case is a concrete outcome with some relevance to the broader Roundup litigation after the Durnell ruling, but its direct impact on many people is limited and the pending $7.25 billion settlement ruling is separate.

Sources (2)

← All stories